Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.00
Bid: 68.00
Ask: 68.80
Change: -1.40 (-2.02%)
Spread: 0.80 (1.176%)
Open: 69.40
High: 69.40
Low: 68.00
Prev. Close: 69.40
GABI Live PriceLast checked at -
GCP Asset Backed Income is an Investment Trust

To generate attractive risk-adjusted returns through growing distributions and modest capital appreciation over the long term by investing in predominantly UK loans.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dividend Declaration & Scrip Dividend Alternative

26 Jul 2018 07:00

RNS Number : 7790V
GCP Asset Backed Income Fund Ltd
26 July 2018
 

GCP Asset Backed Income Fund Limited

(the "Company" or "GCP Asset Backed")

LEI: 213800FBBZCQMP73A815

Dividend Declaration and Scrip Dividend Alternative

26 July 2018

The Board of GCP Asset Backed, which invests in asset backed loans, is pleased to announce its second quarterly dividend in respect of the period from 1 April 2018 to 30 June 2018 of 1.525 pence per ordinary share (the "Q2 Dividend").

The ordinary shares will go ex-dividend on 2 August 2018 and will be paid on 3 September 2018 to holders of ordinary shares recorded on the register as at the close of business on 3 August 2018.

Further to the authority granted by shareholders at the Annual General Meeting of the Company held on 23 May 2017, holders of ordinary shares will be given the opportunity to elect to receive new ordinary shares in the Company ("Scrip Shares") in place of their cash entitlement pursuant to the Q2 Dividend (the "Scrip Dividend Alternative").

Further details of the Scrip Dividend Alternative can be found in the Scrip Dividend Circular 2018 which was published by the Company on 26 April 2018, a copy of which is available for inspection at www.morningstar.co.uk/uk/NSM and on the Company's website at www.graviscapital.com/funds/gcp-asset-backed/literature. The Scrip Dividend Circular 2018 is also available from the Company's registered office at 12 Castle Street, St Helier, Jersey, JE2 3RT, Channel Islands.

The reference price of the Scrip Shares in respect of the Q2 Dividend will be calculated and published on or around 9 August 2018.

Shareholders will receive the Q2 Dividend in cash, unless they have completed either a standing election (a "Scrip Dividend Mandate") (for holders of ordinary shares in certificated form only, with such Scrip Dividend Mandate to be returned to the Company's registrar, Link Asset Services, by no later than 5pm on 17 August 2018) or a Dividend Election Input Message shares (for holders of ordinary shares in CREST only, with such Election to be made in CREST by no later than 5pm on 17 August 2018) to receive Scrip Shares.

Holders of ordinary shares in certificated form who complete a Scrip Dividend Mandate will continue to receive Scrip Shares in lieu of their entire cash dividend entitlement for future dividends unless they revoke their Scrip Dividend Mandate, details of which are set out in the Scrip Dividend Circular 2018.

Expected timetable for Q2 Dividend and Scrip Dividend Alternative

2018

Ex-dividend date 2 August

Record date 3 August

Reference price of Scrip Shares for Q2 Dividend announced 9 August

Latest date for receipt of Scrip Dividend Mandates and CREST elections 5pm on 17 August

Q2 Dividend payment date 3 September

Dealings commence in Scrip Shares 3 September

For further information, please contact:

Gravis Capital Management Limited +44 (0) 20 3405 8500

David Conlon david.conlon@graviscapital.com 

Dion Di Miceli dion.dimiceli@graviscapital.com 

Cenkos Securities plc +44 (0)20 7397 8900

Tom Scrivens tscrivens@cenkos.com 

Oliver Packard opackard@cenkos.com 

Sapna Shah sshah@cenkos.com 

Buchanan +44 (0)20 7466 5000

Charles Ryland charlesr@buchanan.uk.com 

Henry Wilson henryw@buchanan.uk.com 

Notes to EditorsThe Company

GCP Asset Backed is a closed ended investment company traded on the Main Market of the London Stock Exchange. Its investment objective is to generate attractive risk-adjusted returns primarily through regular, growing distributions and modest capital appreciation over the long term.

The Company seeks to meet its investment objective by making investments in a diversified portfolio of predominantly UK based asset backed loans which have contracted, predictable medium to long term cash flows and/or physical assets.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVEASXSALXPEFF
Date   Source Headline
8th Oct 20207:00 amRNSTransaction in Own Shares
7th Oct 20207:00 amRNSTransaction in Own Shares
10th Sep 20207:00 amRNSHalf-Yearly Report & Financial Statements
31st Jul 20207:00 amRNSInvestor Report as at 30 June 2020
23rd Jul 20207:00 amRNSDividend Declaration & Scrip Dividend Suspension
15th Jul 20204:42 pmRNSSecond Price Monitoring Extn
15th Jul 20204:38 pmRNSPrice Monitoring Extension
15th Jul 20207:00 amRNSNet Asset Value and Investment Update
10th Jul 20207:00 amRNSExtension to term of Revolving Credit Facility
7th Jul 20204:22 pmRNSResult of AGM & EGM
17th Jun 20204:36 pmRNSPrice Monitoring Extension
2nd Jun 20207:00 amRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSTotal Voting Rights
26th May 20207:00 amRNSTransaction in Own Shares
22nd May 20207:00 amRNSTransaction in Own Shares
20th May 20204:41 pmRNSSecond Price Monitoring Extn
20th May 20204:37 pmRNSPrice Monitoring Extension
20th May 20207:00 amRNSNotices of AGM & EGM
4th May 20207:00 amRNSInvestor Report as at 31 March 2020
29th Apr 20207:00 amRNSDividend Declaration & Scrip Dividend Suspension
21st Apr 20207:00 amRNSNet Asset Value and Investment Update
7th Apr 20207:00 amRNSAnnual Report & AGM
31st Mar 20207:00 amRNSTotal Voting Rights
25th Mar 20207:00 amRNSTransaction in Own Shares
24th Mar 20207:00 amRNSTransaction in Own Shares
20th Mar 20207:00 amRNSTransaction in Own Shares
19th Mar 20207:00 amRNSAnnual Report & Financial Statements
19th Mar 20207:00 amRNSTransaction in Own Shares
18th Mar 20207:00 amRNSCompliance with Market Abuse Regulation
28th Feb 20209:47 amRNSTotal Voting Rights & Additional Listing
21st Feb 20207:00 amRNSAdditional Listing
17th Feb 20207:00 amRNSInvestment in co-living
6th Feb 20207:00 amRNSScrip Share Reference Price
30th Jan 20207:00 amRNSInvestor report as at 31 December 2019
29th Jan 20207:00 amRNSChange of corporate adviser
22nd Jan 20207:00 amRNSDividend Declaration & Scrip Dividend Alternative
16th Jan 20207:00 amRNSNet Asset Value
16th Jan 20207:00 amRNSRevolving Credit Facility
29th Nov 20199:34 amRNSTotal Voting Rights and Additional Listing
25th Nov 20197:00 amRNSAdditional Listing
7th Nov 201910:08 amRNSScrip Share Reference Price
7th Nov 20197:00 amRNSDirectorate Change
31st Oct 20197:00 amRNSInvestor Report as at 30 September 2019
23rd Oct 20197:00 amRNSDividend Declaration & Scrip Dividend Alternative
23rd Oct 20197:00 amRNSSpecial dividend declaration
15th Oct 20197:00 amRNSNet Asset Value(s)
30th Sep 20197:00 amRNSTotal Voting Rights
10th Sep 20197:00 amRNSHalf-Yearly Report & Financial Statements
2nd Sep 201910:01 amRNSTotal Voting Rights & Additional Listing
22nd Aug 20197:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.